Approval · Notice of Compliance 23441 · 2020
AJOVY: Notice of Compliance 23441
Issued April 9, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23441
- Date
- April 9, 2020
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AJOVY | 02497859 | Marketed |
Medicinal ingredients
- FREMANEZUMAB 225 MG per 1.5ML